Federated Hermes’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.3M Sell
1,432,260
-177,222
-11% -$1.54M 0.02% 566
2025
Q4
$12.1M Buy
1,609,482
+14,650
+0.9% +$149K 0.02% 567
2025
Q3
$13.9M Sell
1,594,832
-72,506
-4% -$433K 0.02% 495
2025
Q2
$6.19M Buy
1,667,338
+417,157
+33% +$1.47M 0.01% 670
2025
Q1
$4.04M Buy
1,250,181
+1,246,419
+33,132% +$5.87M 0.01% 761
2024
Q4
$21K Buy
+3,762
New +$29.5K ﹤0.01% 1765
2024
Q2
Sell
-27
Closed -$860 2054
2024
Q1
$860 Buy
+27
New +$689 ﹤0.01% 1965
2022
Q3
Sell
-219
Closed -$2K 2171
2022
Q2
$2K Buy
+219
New +$2.13K ﹤0.01% 1975
2021
Q3
Sell
-4,200
Closed -$101K 2250
2021
Q2
$101K Sell
4,200
-145,800
-97% -$4.46M ﹤0.01% 1789
2021
Q1
$6.51M Hold
150,000
0.01% 775
2020
Q4
$6.22M Buy
+150,000
New +$6.19M 0.01% 751

Other funds holding FDMT